C. Sire

3.8k total citations · 3 hit papers
23 papers, 2.5k citations indexed

About

C. Sire is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, C. Sire has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Otorhinolaryngology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in C. Sire's work include Head and Neck Cancer Studies (22 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Diagnosis and Treatment (7 papers). C. Sire is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Diagnosis and Treatment (7 papers). C. Sire collaborates with scholars based in France and Switzerland. C. Sire's co-authors include M. Alfonsi, J. Tortochaux, G. Calais, É. Bardet, B. Rhein, Philippe Bergerot, T. Germain, P. Garaud, P. Oudinot and Philippe B. Bertrand and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

C. Sire

23 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma

1999 842 citations G. Calais, M. Alfonsi et al. JNCI Journal of the National Cancer Institute profile →
Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma

2003 673 citations Fabrice Denis, P. Garaud et al. Journal of Clinical Oncology profile →
Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation

2009 369 citations Y. Pointreau, S. Chapet et al. JNCI Journal of the National Cancer Institute profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
C. Sire	2.2k	1.5k	1.0k	895	185	23	2.5k
B. Rhein	1.9k 0.8×	1.3k 0.9×	852 0.8×	741 0.8×	141 0.8×	19	2.2k
Philippe Bergerot	1.6k 0.7×	1.2k 0.8×	872 0.9×	629 0.7×	127 0.7×	13	2.0k
T. Germain	1.5k 0.7×	1.1k 0.7×	694 0.7×	598 0.7×	119 0.6×	15	1.8k
J.-L. Lefebvre	1.4k 0.6×	1.1k 0.7×	671 0.7×	690 0.8×	135 0.7×	29	1.8k
W. Dobrowsky	985 0.4×	793 0.5×	690 0.7×	512 0.6×	103 0.6×	55	1.6k
Christoph Glanzmann	947 0.4×	982 0.6×	1.1k 1.1×	1.0k 1.1×	141 0.8×	59	2.3k
Hélène Audry	1.2k 0.5×	764 0.5×	599 0.6×	479 0.5×	115 0.6×	8	1.4k
F. Adab	997 0.5×	849 0.6×	939 0.9×	906 1.0×	125 0.7×	14	2.2k
Kie-Kian Ang	1.2k 0.6×	833 0.6×	536 0.5×	541 0.6×	93 0.5×	5	1.5k
Louis Portugal	903 0.4×	731 0.5×	402 0.4×	473 0.5×	120 0.6×	43	1.3k

Countries citing papers authored by C. Sire

Since Specialization

Citations

This map shows the geographic impact of C. Sire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sire more than expected).

Fields of papers citing papers by C. Sire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Sire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sire. The network helps show where C. Sire may publish in the future.

Co-authorship network of co-authors of C. Sire

This figure shows the co-authorship network connecting the top 25 collaborators of C. Sire. A scholar is included among the top collaborators of C. Sire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Sire. C. Sire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tao, Yuan, A. Aupérin, Xinzhi Sun, et al.. (2024). 854MO Avelumab-cetuximab-radiotherapy (RT) versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Final analysis of randomized phase III GORTEC 2017-01 REACH trial. Annals of Oncology. 35. S616–S616. 7 indexed citations

Pointreau, Y., M. Alfonsi, C. Sire, et al.. (2020). Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial. European Journal of Cancer. 133. 86–93. 15 indexed citations

Pointreau, Y., P. Garaud, S. Chapet, et al.. (2015). Long-Term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation. JNCI Journal of the National Cancer Institute. 108(4). 111 indexed citations

Pointreau, Y., P. Garaud, S. Chapet, et al.. (2015). Long-term results of GORTEC 2000-01: A multicentric randomized phase III trial of induction chemotherapy with cisplatin plus 5-fluorouracil, with or without docetaxel, for larynx preservation.. Journal of Clinical Oncology. 33(15_suppl). 6002–6002. 13 indexed citations

Calais, G., S. Chapet, Y. Pointreau, et al.. (2010). Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma: Ten-year results of the 94-01 GORTEC randomized study.. Journal of Clinical Oncology. 28(15_suppl). 5516–5516. 1 indexed citations

Pointreau, Y., S. Chapet, C. Sire, et al.. (2009). Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation. JNCI Journal of the National Cancer Institute. 101(7). 498–506. 369 indexed citations breakdown →

Pointreau, Y., S. Chapet, C. Sire, et al.. (2009). Évaluation à long terme de la voix et de la déglutition dans le cadre de l’essai de phase III randomisé de préservation laryngée 2000–01 du Gortec. Cancer/Radiothérapie. 13(6-7). 680–680. 1 indexed citations

Calais, G., Y. Pointreau, M. Alfonsi, et al.. (2007). 5500 ORAL Induction chemotherapy for larynx preservation. Updated results of the GORTEC 2000–01 randomized trial comparing docetaxel + cisplatinum + fluorouracil (TPF) versus cisplatinum + fluorouracil (PF). European Journal of Cancer Supplements. 5(4). 324–324. 5 indexed citations

Pointreau, Y., M. Alfonsi, C. Sire, et al.. (2006). Premiers résultats de l'essai de phase III GORTEC 2000-01 comparant deux schémas de chimiothérapie d'induction par cisplatine et 5-fluoro-uracile avec ou sans docetaxel dans le but de préserver le larynx. Cancer/Radiothérapie. 10(6-7). 493–493. 1 indexed citations

10.

Calais, G., Y. Pointreau, M. Alfonsi, et al.. (2006). Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000–01. Journal of Clinical Oncology. 24(18_suppl). 5506–5506. 58 indexed citations

11.

Bourhis, Jean, G. Calais, M. Lapeyre, et al.. (2004). Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Seminars in Oncology. 31(6). 822–826. 31 indexed citations

12.

Calais, G., É. Bardet, C. Sire, et al.. (2003). Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. International Journal of Radiation Oncology*Biology*Physics. 58(1). 161–166. 83 indexed citations

13.

Denis, Fabrice, P. Garaud, É. Bardet, et al.. (2003). Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma. Journal of Clinical Oncology. 22(1). 69–76. 673 indexed citations breakdown →

14.

Denis, Fabrice, P. Garaud, É. Bardet, et al.. (2002). Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. International Journal of Radiation Oncology*Biology*Physics. 55(1). 93–98. 170 indexed citations

15.

Calais, G., M. Alfonsi, É. Bardet, et al.. (2001). Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. final results of the 94-01 GORTEC randomized study. International Journal of Radiation Oncology*Biology*Physics. 51(3). 1–2. 9 indexed citations

16.

Denis, Fabrice, M. Alfonsi, É. Bardet, et al.. (2001). Late toxicity results of randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma (GORTEC 94-01). International Journal of Radiation Oncology*Biology*Physics. 51(3). 39–39. 4 indexed citations

17.

Calais, G., M. Alfonsi, É. Bardet, et al.. (2000). [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy].. PubMed. 87 Spec No. 48–53. 25 indexed citations

18.

Calais, G., M. Alfonsi, É. Bardet, et al.. (1999). Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma. JNCI Journal of the National Cancer Institute. 91(24). 2081–2086. 842 indexed citations breakdown →

19.

Calais, G., É. Bardet, C. Sire, et al.. (1999). 2179 Radiation therapy with concomitant weekly docetaxel in stages III and IV non metastatic oral cavity and oropharynx carcinomas. Results of the gortec 98-02 phase II study. International Journal of Radiation Oncology*Biology*Physics. 45(3). 370–370. 1 indexed citations

20.

Calais, G., M. Alfonsi, C. Sire, et al.. (1996). 49 Randomized study comparing radiation alone (RT) versus RT and concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. Preliminary results: treatment compliance and acute toxicity. Radiotherapy and Oncology. 40. S15–S15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact